
    
      Patients aged less than 2 years with recurrent wheezing. At visit 1 patients with symptoms
      will be enrolled and the study explained. They will return home with bronchodilator therapy.

      Within 1 week they will return for visit 2 to start a run-in period with bronchodilators prn
      and they will fill dairies with symptoms and drug use. Skin prick test will be evaluated at
      that time.

      At visit 3 after 1 week of the run-in period they will start therapy with Montelukast 4 mg
      for 4 weeks, using bronchodilators prn and filling diaries.

      The final visit will be after four weeks with re-evaluation of the lung function
    
  